#USA #San Francisco #Securities Class Action #revenue accounting #Veritone Inc

Veritone Inc. Faces Class Action Over Revenue Accounting Issues

Veritone, Inc. (NASDAQ: VERI) is now the center of a securities class action lawsuit, representing investors who purchased or acquired Veritone securities from October 14, 2025, to April 14, 2026. This lawsuit follows the company’s admission that certain previously filed financial documents should no longer be considered reliable. Following multiple revelations regarding its accounting practices, Veritone's share price has plummeted dramatically, sparking the interest of legal representatives looking to protect aggrieved investors.

The catalyst for this legal action stems from Veritone's alarming revelation that specific financial records had been prepared using improper accounting methods. The continuity of incorrect revenue and cost reporting allegedly misled investors about the company's actual financial performance. According to the lawsuit, this led to significant overstatements in revenue figures, accounts receivable, royalties, and other income categories.

An investigation by law firm Hagens Berman was initiated due to these developments, with the firm actively encouraging adversely affected investors to come forward with their experiences. As a result, the lawsuit highlights the essential timeline where misleading information was disclosed to the public. The first significant drop in Veritone’s stock occurred on March 26, 2026, when the company made a surprise announcement concerning its preliminary fourth quarter 2025 revenues. The subsequent drop of over 29% in share price signaled the beginning of a troubling trend.

On April 1, 2026, Veritone disclosed that it would delay its annual report, attributing the postponement to challenges in finalizing the accounting of certain revenue transactions. This heightened uncertainty prompted yet another drop of around 9% in its stock value. Later, on April 14, the company revealed even more damaging information, stating, “the Company’s previously issued unaudited financial statements for the three and nine months ended September 30, 2025 should no longer be relied upon.” This announcement was triggered by significant accounting missteps leading to inflated revenue and understated net losses.

The lawsuit’s investigation aims to determine whether Veritone and its management intentionally deceived investors regarding the company's financial standing through the now-recognized incorrect accounting practices. Reed Kathrein, the leading partner at Hagens Berman overseeing this investigation, noted, “Our investigation is focused on whether Veritone and its management intentionally misled investors about its financial performance using now-admitted improper accounting.”

This class action suit highlights a significant issue for investors who believe they have incurred substantial losses due to the misleading financial disclosures from Veritone. The legal team is encouraging those with knowledge or evidence to step forward, reinforcing the importance of corporate accountability and transparency. Those who have experienced losses or possess relevant information are urged to reach out to Hagens Berman to contribute to the ongoing investigation.

For those feeling isolated in this situation, there are options available, including whistleblower protections through the SEC's Whistleblower program. Individuals with original information may potentially earn rewards that can encompass a substantial portion of any successful recovery made by the SEC. The importance of whistleblower avenues highlights the broader commitment to rooting out fraud in corporate practices and ensuring investors have an opportunity to reclaim their losses.

As Veritone navigates these turbulent waters, the ramifications not only impact the company’s reputation but also the trust between investors and corporate governance practices. The outcome of this lawsuit could have lasting implications for both Veritone and the industry as a whole, highlighting the critical need for accuracy in financial reporting and adherence to regulatory standards. Investors remain vigilant as this story unfolds, with many watching closely how Veritone addresses these challenges moving forward.